COVID-19 updates: Mucormycosis not contagious, says AIIMS chief; walk-ins for 18-44 allowed at govt centres
FirstpostAIIMS director Randeep Guleria on Monday said it is better to identify mucormycosis by its name rather than by the colour as labelling the same fungus with names of different colours can create confusion. Meanwhile, India’s COVID-19 daily recoveries have outnumbered new cases for the 11th consecutive day, while the cumulative positivity rate stands at 8.09 percent, the Union health ministry said in a briefing on Monday. States and UT must decide on the opening of on-site registrations/facilitated cohorts’ registration and appointments for 18-44 years age group based on the local context just as an additional measure to minimize vaccine wastage and for facilitating vaccination of eligible beneficiaries in the age group of 18-44 years, the ministry said in its statement. “Launch of production in India in partnership with Panacea Biotec marks an important step in helping the country fight the pandemic,” RDIF chief executive Kirill Dmitriev said. On the development, Panacea Biotec MD Rajesh Jain said, “This marks a significant step as we initiate production of Sputnik V. Together with RDIF, we hope to help bring a sense of normalcy back to people across the country and around the world.” Sputnik V was registered in India under the emergency use authorisation procedure on 12 April, 2021, and vaccination against coronavirus with the Russian vaccine started on 14 May.